Zydus Lifesciences informs about press release

09 Mar 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated March 9, 2022 titled ‘Zydus receives final approval from USFDA for Nitroglycerin Sublingual Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1004.00 2.15 (0.21%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.